US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Articles published by Tarsus Pharmaceuticals, Inc

< Previous 1 2 Next >
News headline image
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conference
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conference
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus to Participate in Upcoming Investor Conferences
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
News headline image
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tickers TARS
< Previous 1 2 Next >